JENBURKT PHARMACEUTICALS
Back to Income Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Revenue History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Sales | ₹152 Cr | ₹142 Cr | ₹137 Cr | ₹124 Cr | ₹109 Cr |
What is the latest Revenue of JENBURKT PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2025 | ₹152 Cr |
Mar2024 | ₹142 Cr |
Mar2023 | ₹137 Cr |
Mar2022 | ₹124 Cr |
Mar2021 | ₹109 Cr |
How is Revenue of JENBURKT PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2025 | ₹152 Cr | 6.85 | |
Mar2024 | ₹142 Cr | 3.82 | |
Mar2023 | ₹137 Cr | 10.30 | |
Mar2022 | ₹124 Cr | 13.44 | |
Mar2021 | ₹109 Cr | - |
Compare Revenue of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹573.7 Cr | -4.3% | -2.3% | 49.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹414,533.0 Cr | 3.6% | 2.5% | 6.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,215.0 Cr | -2.9% | 1.5% | 48.1% | Stock Analytics | |
CIPLA | ₹120,428.0 Cr | -0.1% | -2.4% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹116,410.0 Cr | 2.5% | 4.9% | 15.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,253.0 Cr | -0.7% | -6.4% | -5.2% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -4.3% |
-2.3% |
49.1% |
SENSEX | -1.4% |
1.8% |
3.3% |
You may also like the below Video Courses